Lawrence Mehren

Lawrence Mehren

Chairman at
Avery Therapeutics, Inc.

Net worth: 3 377 $ as of 2026-10-30

59 year
Health Technology
Finance
Consumer Services

Profile

Lawrence L.
Mehren
is Chairman at Avery Therapeutics, Inc. since 2022.
Mr. Mehren is Independent Director at Lumos Diagnostics since 2021.
Mr. Mehren is Manager at Abeja Ventures LLC.
Formerly, Mr. Mehren was President, Chief Executive Officer & Director at Accelerate Diagnostics, Inc. from 2012 to 2020.
Mr. Mehren was Director-New Business Development at Thomson Corp.
from 1995 to 2000.
Mr. Mehren was Managing Director, Partner & Head-Life Sciences at P&M Corporate Finance LLC from 2000 to 2007.
Mr. Mehren was Non-Executive Director at Lumos Diagnostics Holdings Ltd. from 2020 to 2026.
Mr. Mehren was Head-Global Business at Ventana Medical Systems, Inc. from 2009 to 2011.
Education includes undergraduate studies at the University of Arizona and an MBA from Kellogg School of Management.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-10-11 80,000 ( 0.01% ) 3 377 $ 2026-10-30

Lawrence Mehren active positions

CompaniesPositionStart
Chairman 2022-01-31
Director/Board Member 2021-05-04
Corporate Officer/Principal -

Former positions of Lawrence Mehren

CompaniesPositionEnd
LUMOS DIAGNOSTICS HOLDINGS LIMITED Director/Board Member 2026-10-11
ACCELERATE DIAGNOSTICS, INC. Chief Executive Officer 2020-01-30
Director of Finance/CFO 2007-12-31
Corporate Officer/Principal 2006-12-31
Corporate Officer/Principal 1999-12-31
See the detail of Lawrence Mehren's experience

Education of Lawrence Mehren

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

60

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Technology Services

Electronic Technology

Finance

Finance

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Lawrence Mehren